NM_058216.3:c.1027-2A>T
Variant names: 
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_058216.3(RAD51C):c.1027-2A>T variant causes a splice acceptor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: not found (cov: 32) 
Consequence
 RAD51C
NM_058216.3 splice_acceptor, intron
NM_058216.3 splice_acceptor, intron
Scores
 4
 2
 1
 Splicing: ADA:  1.000  
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  3.58  
Publications
0 publications found 
Genes affected
 RAD51C  (HGNC:9820):  (RAD51 paralog C) This gene is a member of the RAD51 family. RAD51 family members are highly similar to bacterial RecA and Saccharomyces cerevisiae Rad51 and are known to be involved in the homologous recombination and repair of DNA. This protein can interact with other RAD51 paralogs and is reported to be important for Holliday junction resolution. Mutations in this gene are associated with Fanconi anemia-like syndrome. This gene is one of four localized to a region of chromosome 17q23 where amplification occurs frequently in breast tumors. Overexpression of the four genes during amplification has been observed and suggests a possible role in tumor progression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013] 
RAD51C Gene-Disease associations (from GenCC):
- breast-ovarian cancer, familial, susceptibility to, 3Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Fanconi anemia complementation group OInheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
- hereditary breast ovarian cancer syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 1.3209549 fraction of the gene. Cryptic splice site detected, with MaxEntScore 11, offset of 6, new splice context is: tttttatctttctgcctcAGgga.  Cryptic site results in inframe change. If cryptic site found is not functional and variant results in exon loss, it results in inframe change. 
PM2
Very rare variant in population databases, with high coverage; 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD3 genomes 
Cov.: 
32
GnomAD4 exome Cov.: 31 
GnomAD4 exome 
Cov.: 
31
GnomAD4 genome  
GnomAD4 genome 
Cov.: 
32
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_addAF 
 Pathogenic 
D 
 BayesDel_noAF 
 Pathogenic 
 DANN 
 Uncertain 
 Eigen 
 Pathogenic 
 Eigen_PC 
 Pathogenic 
 FATHMM_MKL 
 Uncertain 
D 
 PhyloP100 
 GERP RS 
Splicing
Name
Calibrated prediction
Score
Prediction
 dbscSNV1_ADA 
 Pathogenic 
 dbscSNV1_RF 
 Pathogenic 
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 DS_AG_spliceai 
Position offset: 8
 DS_AL_spliceai 
Position offset: 2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.